Immunology News and Research

Latest Immunology News and Research

Climate change emerges as major eczema trigger

In an analysis of all relevant published studies that assessed atopic dermatitis (also known as eczema) associated with trends in climate-related hazards due to greenhouse gas emissions, investigators found that impacts include direct effects on eczema, like particulate matter-induced inflammation from wildfires, and indirect effects, such as stress resulting from drought-induced food insecurity.

24 Jan 2024

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

From Calluna Pharma 24 Jan 2024

New atlas reveals a slew of cellular and molecular interactions that drive ovulation

An interdisciplinary collaboration used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice.

23 Jan 2024

Study reveals surprising power of CD4+ T cells against melanoma

In the study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and published in Science Immunology, the researchers found that CD4+ T cells, traditionally called ‘helper T cells’ for their role in aiding the activation of other immune cells, are remarkably effective in controlling melanoma.

22 Jan 2024

Memory T cells learn and adapt: Post-Omicron immunity offers wider protection

It has been 4 years since the start of the COVID-19 pandemic. SARS-CoV-2 has yet to be eradicated and new variants are continuously emerging.

19 Jan 2024

Researchers make new breakthrough in better understanding the immune system to fight diseases

The Xue Lab at the Hackensack Meridian Center for Discovery and Innovation (CDI) has made another breakthrough in better understanding, and potentially modulating, the immune system to fight diseases.

18 Jan 2024

Nutrition's pivotal role in combating tuberculosis: addressing N-AIDS for better outcomes

Review highlights the critical role of nutritionally acquired immunodeficiency syndrome (N-AIDS) in tuberculosis (TB) management, emphasizing the need for integrated nutritional screening and care in TB programs.

18 Jan 2024

Prior mycobacterium exposure remodels immune cells, impacting tuberculosis defense

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) kills upwards of 1.6 million people a year, making it one of the leading causes of death by an infectious agent worldwide-;and that number is only growing larger.

18 Jan 2024

New structural insights pave the way for drug-resistant malaria therapies

Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.

18 Jan 2024

Monkey study points to HIV vulnerability for vaccine attack

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people.

17 Jan 2024

INSIS study unveils secrets of rare vaccine events, shaping future immunizations

A University of Alberta professor is co-leading a new international vaccine safety network to examine why some people who received a COVID-19 vaccine experienced very rare adverse events associated with the vaccine.

17 Jan 2024

Breakthrough nano-shield blocks selective allergic reactions

Northwestern University researchers have developed the first selective therapy to prevent allergic reactions, which can range in severity from itchy hives and watery eyes to trouble breathing and even death.

16 Jan 2024

Immune dysregulation in long COVID patients uncovered in new study

Sstudy reveals significant immune changes in long COVID patients, including altered T cell responses and systemic inflammation, using advanced 'omics' and serological assays.

14 Jan 2024

Researchers uncover role of persister cells in antibiotic resistance

Antibiotic overuse can lead to antibiotic resistance, but classic antibiotic resistance might not completely explain why antibiotics sometimes fail.

12 Jan 2024

Defective gene triggers uncontrolled immune attack in young lupus patients

A group of researchers lead by Min Ae Lee-Kirsch from the Department of Pediatrics, Medical Faculty, TUD Dresden University of Technology (Germany), studied four patients from two families who developed symptoms of SLE in the first years of life.

12 Jan 2024

New molecule targets key protein in autoimmune diseases

Scientists from Scripps Research have developed a small molecule that blocks the activity of a protein linked to autoimmune diseases, including systemic lupus erythematosus (SLE) and Crohn's disease.

11 Jan 2024

BCG vaccine's impact on innate immunity explained at cellular level

Bacillus Calmette-Guérin (BCG) is one of the world’s oldest and most widely used vaccines. It was developed in the early 20th century to provide protection from tuberculosis.

9 Jan 2024

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives.

From Cellular Origins 9 Jan 2024

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

Measuring airborne grass allergen levels instead of pollen counts will be more beneficial for hay fever sufferers as new research shows grass allergen levels are more consistently associated with hay fever symptoms than grass pollen counts.

8 Jan 2024

First-of-its-kind research shines light on how certain pathogens can outwit the body's immune system

In a first-of-its-kind research breakthrough, a team of scientists at the University of Massachusetts Amherst has analyzed and described what they call the "mosquito effect," which sheds light on how certain pathogens, such as cancerous tumor cells, can outwit the body's immune system.

8 Jan 2024

Immunology News and Research

Latest Immunology News and Research

Climate change emerges as major eczema trigger

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

New atlas reveals a slew of cellular and molecular interactions that drive ovulation

Study reveals surprising power of CD4+ T cells against melanoma

Memory T cells learn and adapt: Post-Omicron immunity offers wider protection

Researchers make new breakthrough in better understanding the immune system to fight diseases

Nutrition's pivotal role in combating tuberculosis: addressing N-AIDS for better outcomes

Prior mycobacterium exposure remodels immune cells, impacting tuberculosis defense

New structural insights pave the way for drug-resistant malaria therapies

Monkey study points to HIV vulnerability for vaccine attack

INSIS study unveils secrets of rare vaccine events, shaping future immunizations

Breakthrough nano-shield blocks selective allergic reactions

Immune dysregulation in long COVID patients uncovered in new study

Researchers uncover role of persister cells in antibiotic resistance

Defective gene triggers uncontrolled immune attack in young lupus patients

New molecule targets key protein in autoimmune diseases

BCG vaccine's impact on innate immunity explained at cellular level

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

First-of-its-kind research shines light on how certain pathogens can outwit the body's immune system

Immunology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer